Log in to save to my catalogue

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence...

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d394bf34eeae42fea27d107f60913bf0

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy

About this item

Full title

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy

Publisher

England: BioMed Central Ltd

Journal title

Radiation oncology (London, England), 2018-03, Vol.13 (1), p.37-9, Article 37

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

PSMA PET/CT visualises prostate cancer residual disease or recurrence at lower PSA levels compared to conventional imaging and results in a change of treatment in a remarkable high number of patients. Radiotherapy with dose escalation to the former prostate bed has been associated with improved biochemical recurrence-free survival. Thus, it can be...

Alternative Titles

Full title

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d394bf34eeae42fea27d107f60913bf0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d394bf34eeae42fea27d107f60913bf0

Other Identifiers

ISSN

1748-717X

E-ISSN

1748-717X

DOI

10.1186/s13014-018-0983-4

How to access this item